Skip to content

Effect Of Use Of Entropy Monitoring On Consumption Of Sevoflurane Inhalational Agent In Patients Undergoing Off-Pump Coronary Artery Bypass Graft Surgery

Effect Of Use Of Entropy Monitoring On Consumption Of Sevoflurane Inhalational Agent In Patients Undergoing Off - Pump Coronary Artery Bypass Graft Surgery : A Randomiszed, Double Blinded, Controlled Study At S.M.S. Medical College And Attached Hospitals, Jaipur During 2020 - 2021

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/12/029923
Enrollment
60
Registered
2020-12-18
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I011- Acute rheumatic endocarditis

Interventions

Intervention1: Entropy Monitoring: 3-electrode sensor applied on patients forehead to record EEG activity of brain and give a numerical value to assess anesthetic depth. Control Intervention1: nil: ni

Sponsors

SMS Medical College And Attached Hospitals
Lead Sponsor
sms medical college
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: Patients undergoing OP-CABG surgery Ejection Fraction >45% ASA Grade 2 & 3

Exclusion criteria

Exclusion criteria: Diabetes Mellitus, bleeding disorders, electrolyte imbalance etc.

Design outcomes

Primary

MeasureTime frame
1. Anesthetic depth measured by Entropy Monitoring 2. Difference in mean dose of Sevoflurane consumption at the end of surgery 3. time to regain consciousness as seen by eye opening on command.Timepoint: till the completion of sample size

Secondary

MeasureTime frame
1. hemodynamic parameter changes 2. side effects experienced, if anyTimepoint: till the completion of sample size

Countries

India

Contacts

Public ContactVirali Trivedi

S.M.S. Medical College and Hospital

dr.induverma@gmail.com9413622967

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026